These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17824361)

  • 1. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):33-47. PubMed ID: 17824361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2007 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2009; 33(3 Suppl 2):41-56. PubMed ID: 19776486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2010 activity].
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2012; 36(6 Suppl 1):39-54. PubMed ID: 23293270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extension of organized cervical cancer screening programmes in Italy and their process indicators, 2011-2012 activity.
    Ronco G; Giubilato P; Carozzi F; Maia G; Giorgi Rossi P; Zappa M;
    Epidemiol Prev; 2015; 39(3 Suppl 1):61-76. PubMed ID: 26405778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extension of organised cervical cancer screening programmes in Italy and their process indicators: 2008 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2010; 34(5-6 Suppl 4):35-51. PubMed ID: 21220836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of organised cervical cancer screening programmes in Italy and their process indicators.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2008; 32(2 Suppl 1):37-54. PubMed ID: 18770994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity level and process indicators of organised programmes for cervical cancer screening in Italy.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Federici A; Angeloni C; Prandini S; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2006; 30(1 Suppl 3):27-40. PubMed ID: 16937844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extension of organised cervical cancer screening programmes in Italy and their process indicators, 2009 activity.
    Ronco G; Giubilato P; Naldoni C; Zorzi M; Anghinoni E; Scalisi A; Dalla Palma P; Zanier L; Barca A; Angeloni C; Gaimo MD; Maglietta R; Mancini E; Pizzuti R; Iossa A; Segnan N; Zappa M
    Epidemiol Prev; 2011; 35(5-6 Suppl 5):39-54. PubMed ID: 22166349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Health technology assessment report: HPV DNA based primary screening for cervical cancer precursors].
    Ronco G; Biggeri A; Confortini M; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Accetta G; Giordano L; Cogo C; Carozzi F; Gillio Tos A; Arbyn M; Mejier CJ; Snijders PJ; Cuzick J; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(3-4 Suppl 1):e1-72. PubMed ID: 22828243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quality of colposcopy and treatment: data from the national survey of Italian organised cervical screening programmes.
    Volante R; Giubilato P; Ronco G
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):61-8. PubMed ID: 17824363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A first survey of HPV-based screening in routine cervical cancer screening in Italy.
    Ronco G; Giorgi Rossi P; Giubilato P; Del Mistro A; Zappa M; Carozzi F;
    Epidemiol Prev; 2015; 39(3 Suppl 1):77-83. PubMed ID: 26405779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a high-risk human papillomavirus DNA test as the primary test in a cervical cancer screening programme: a population-based cohort study.
    Zorzi M; Del Mistro A; Farruggio A; de'Bartolomeis L; Frayle-Salamanca H; Baboci L; Bertazzo A; Cocco P; Fedato C; Gennaro M; Marchi N; Penon MG; Cogo C; Ferro A
    BJOG; 2013 Sep; 120(10):1260-7; discussion 1267-8. PubMed ID: 23786222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Health technology assessment report. Use of liquid-based cytology for cervical cancer precursors screening].
    Ronco G; Confortini M; Maccallini V; Naldoni C; Segnan N; Sideri M; Zappa M; Zorzi M; Calvia M; Giorgi Rossi P
    Epidemiol Prev; 2012; 36(5 Suppl 2):e1-e33. PubMed ID: 23139163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Performance indicators of organized cervical screening in Romagna (Italy).
    Bucchi L; Falcini F; Schincaglia P; Desiderio F; Bondi A; Farneti M; Casadei Giunchi D; Serafini M; Canuti D; Caprara L; Sabbadini F; Monari F; Sassoli P
    Eur J Cancer Prev; 2003 Jun; 12(3):223-8. PubMed ID: 12771561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cervical cancer screening in immigrant women in Italy: a survey on participation, cytology and histology results.
    Campari C; Fedato C; Iossa A; Petrelli A; Zorzi M; Anghinoni E; Bietta C; Brachini A; Brezzi S; Cogo C; Giordano L; Giorgi D; Palazzi M; Petrella M; Schivardi MR; Visioli CB; Giorgi Rossi P;
    Eur J Cancer Prev; 2016 Jul; 25(4):321-8. PubMed ID: 26207563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time trends of process and impact indicators in Italian mammography screening programmes--1996-2004.
    Giordano L; Giorgi D; Piccini P; Ventura L; Stefanini V; Senore C; Paci E; Segnan N
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):21-32. PubMed ID: 17824360
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 3-year interval is too short for re-screening women testing negative for human papillomavirus: a population-based cohort study.
    Zorzi M; Frayle H; Rizzi M; Fedato C; Rugge M; Penon MG; Bertazzo A; Callegaro S; Campagnolo M; Ortu F; Del Mistro A;
    BJOG; 2017 Sep; 124(10):1585-1593. PubMed ID: 28120382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test.
    Ronco G; Giorgi-Rossi P; Carozzi F; Confortini M; Dalla Palma P; Del Mistro A; Gillio-Tos A; Minucci D; Naldoni C; Rizzolo R; Schincaglia P; Volante R; Zappa M; Zorzi M; Cuzick J; Segnan N;
    J Natl Cancer Inst; 2008 Apr; 100(7):492-501. PubMed ID: 18364502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for colorectal cancer in Italy: 2005 survey.
    Zorzi M; Barca A; Falcini F; Grazzini G; Pizzuti R; Ravaioli A; Sassoli de Bianchi P; Senore C; Sigillito A; Vettorazzi M; Visioli C
    Epidemiol Prev; 2007; 31(2-3 Suppl 2):49-60. PubMed ID: 17824362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
    C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
    Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.